TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease

Dry eye disease (DED) is commonly associated with ocular surface inflammation and pain. In this study, we evaluated the effectiveness of repeated instillations of transient receptor potential melastatin 8 (TRPM8) ion channel antagonist M8-B on a mouse model of severe DED induced by the excision of e...

Full description

Bibliographic Details
Main Authors: Darine Fakih, Christophe Baudouin, Annabelle Réaux-Le Goazigo, Stéphane Mélik Parsadaniantz
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/22/8756
_version_ 1797547347790528512
author Darine Fakih
Christophe Baudouin
Annabelle Réaux-Le Goazigo
Stéphane Mélik Parsadaniantz
author_facet Darine Fakih
Christophe Baudouin
Annabelle Réaux-Le Goazigo
Stéphane Mélik Parsadaniantz
author_sort Darine Fakih
collection DOAJ
description Dry eye disease (DED) is commonly associated with ocular surface inflammation and pain. In this study, we evaluated the effectiveness of repeated instillations of transient receptor potential melastatin 8 (TRPM8) ion channel antagonist M8-B on a mouse model of severe DED induced by the excision of extra-orbital lacrimal and Harderian glands. M8-B was topically administered twice a day from day 7 until day 21 after surgery. Cold and mechanical corneal sensitivities and spontaneous ocular pain were monitored at day 21. Ongoing and cold-evoked ciliary nerve activities were next evaluated by electrophysiological multi-unit extracellular recording. Corneal inflammation and expression of genes related to neuropathic pain and inflammation were assessed in the trigeminal ganglion. We found that DED mice developed a cold allodynia consistent with higher TRPM8 mRNA expression in the trigeminal ganglion (TG). Chronic M8-B instillations markedly reversed both the corneal mechanical allodynia and spontaneous ocular pain commonly associated with persistent DED. M8-B instillations also diminished the sustained spontaneous and cold-evoked ciliary nerve activities observed in DED mice as well as inflammation in the cornea and TG. Overall, our study provides new insight into the effectiveness of TRPM8 blockade for alleviating corneal pain syndrome associated with severe DED, opening a new avenue for ocular pain management.
first_indexed 2024-03-10T14:43:00Z
format Article
id doaj.art-83768fac1bd542f5ac29929d51d46d7e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T14:43:00Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-83768fac1bd542f5ac29929d51d46d7e2023-11-20T21:36:19ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-11-012122875610.3390/ijms21228756TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye DiseaseDarine Fakih0Christophe Baudouin1Annabelle Réaux-Le Goazigo2Stéphane Mélik Parsadaniantz3Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceSorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, FranceDry eye disease (DED) is commonly associated with ocular surface inflammation and pain. In this study, we evaluated the effectiveness of repeated instillations of transient receptor potential melastatin 8 (TRPM8) ion channel antagonist M8-B on a mouse model of severe DED induced by the excision of extra-orbital lacrimal and Harderian glands. M8-B was topically administered twice a day from day 7 until day 21 after surgery. Cold and mechanical corneal sensitivities and spontaneous ocular pain were monitored at day 21. Ongoing and cold-evoked ciliary nerve activities were next evaluated by electrophysiological multi-unit extracellular recording. Corneal inflammation and expression of genes related to neuropathic pain and inflammation were assessed in the trigeminal ganglion. We found that DED mice developed a cold allodynia consistent with higher TRPM8 mRNA expression in the trigeminal ganglion (TG). Chronic M8-B instillations markedly reversed both the corneal mechanical allodynia and spontaneous ocular pain commonly associated with persistent DED. M8-B instillations also diminished the sustained spontaneous and cold-evoked ciliary nerve activities observed in DED mice as well as inflammation in the cornea and TG. Overall, our study provides new insight into the effectiveness of TRPM8 blockade for alleviating corneal pain syndrome associated with severe DED, opening a new avenue for ocular pain management.https://www.mdpi.com/1422-0067/21/22/8756corneaelectrophysiologyinflammationdry eyeTRPM8 antagonist
spellingShingle Darine Fakih
Christophe Baudouin
Annabelle Réaux-Le Goazigo
Stéphane Mélik Parsadaniantz
TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
International Journal of Molecular Sciences
cornea
electrophysiology
inflammation
dry eye
TRPM8 antagonist
title TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
title_full TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
title_fullStr TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
title_full_unstemmed TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
title_short TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease
title_sort trpm8 a therapeutic target for neuroinflammatory symptoms induced by severe dry eye disease
topic cornea
electrophysiology
inflammation
dry eye
TRPM8 antagonist
url https://www.mdpi.com/1422-0067/21/22/8756
work_keys_str_mv AT darinefakih trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease
AT christophebaudouin trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease
AT annabellereauxlegoazigo trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease
AT stephanemelikparsadaniantz trpm8atherapeutictargetforneuroinflammatorysymptomsinducedbyseveredryeyedisease